Kindred Biosciences Announces Two New Appointments to Board of Directors
News provided by
Share this article
Share this article
SAN FRANCISCO, Feb. 9, 2021 /PRNewswire/ Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it has appointed Lyndon Lien, Ph.D., an experienced biotech CEO, entrepreneur and investor, and Nanxi Liu, CEO and Co-Founder of Enplug and Co-Founder of Nanoly Bioscience, to its Board of Directors, effective February 5, 2021. We are very pleased to welcome Lyndon and Nanxi to our Board, said Chief Executive Officer, Richard Chin, M.D. With extensive investing, operating, and business development experience, Lyndon will bring valuable additional perspectives to KindredBio. Nanxi is a seasoned entrepreneur recognized by Forbes and Fortune magazines, who brings management and public board experience to KindredBio. We look forward to working with them as we advance our in
Meet the 2021 Honorees
Kiesha Nix
Kiesha Nix is currently the Executive Director of the Lakers Youth Foundation. In her current role, Kiesha oversees and directs programming and funding priorities for the charitable arm of the Los Angeles Lakers. She is responsible for implementing the mission of the Foundation which is to assist underserved youth in our communities to develop and recognize their full potential by providing positive experiences and resources in education, health & wellness and sports.
Read Full Bio
Kiesha oversees the funding which supports over 100,000 youth in 20+ Southern California Boys & Girls Clubs through the Jr. Lakers Youth Basketball Program, has helped to build 40+ basketball courts throughout Los Angeles and surrounding counties, 15+ Reading Rooms and currently has completed 2 STEM Lab projects at local middle and high schools in Los Angeles. This funding also awards monetary grants to non-profit organizations that support youth with direct services